VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
CECelanese Corporation
$51.16$5.7B
Research
Overview
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist

CE logoCelanese Corporation(CE)Earnings, Financials & Key Ratios

CE•NYSE
Price updated Jun 19, 2026
SectorBasic MaterialsIndustryChemicalsSub-IndustrySpecialty polymers and additives
AboutCelanese Corporation, a technology and specialty materials company, manufactures and sells high performance engineered polymers in the United States and internationally. The company operates through three segments: Engineered Materials, Acetate Tow, and Acetyl Chain. The Engineered Materials segment develops, produces, and supplies specialty polymers for automotive and medical applications, as well as for use in industrial products and consumer electronics. It also offers acesulfame potassium, a sweetener for use in various beverages, confections, and dairy products; and food protection ingredients, such as potassium sorbate and sorbic acid for use in foods, beverages, and personal care products. The Acetate Tow segment provides acetate tows and flakes for use in filter products applications. The Acetyl Chain segment produces and supplies acetyl products, including acetic acid, vinyl acetate monomers, acetic anhydride, and acetate esters that are used as starting materials for colorants, paints, adhesives, coatings, and pharmaceuticals; and organic solvents and intermediates for pharmaceutical, agricultural, and chemical products. It also offers vinyl acetate-based emulsions for use in paints and coatings, adhesives, construction, glass fiber, textiles, and paper applications; and ethylene vinyl acetate resins and compounds, as well as low-density polyethylene for use in flexible packaging films, lamination film products, hot melt adhesives, automotive parts, and carpeting applications. In addition, it manufactures ultra-high molecular weight polyethylene. Celanese Corporation was founded in 1918 and is headquartered in Irving, Texas.Show more
  • Revenue$9.54B-7.2%
  • EBITDA$1.51B+1098.4%
  • Net Income-$1.17B+23.5%
  • EPS (Diluted)-10.64+23.6%
  • Gross Margin18.77%-18.1%
  • EBITDA Margin15.82%+1190.8%
  • Operating Margin8.04%+218.5%
  • Net Margin-12.21%+17.6%
  • ROE-23.11%

CE Key Insights

Celanese Corporation (CE) fundamental analysis — strengths, weaknesses & financial health based on data analysis

✓Strengths

  • ✓Strong 5Y sales CAGR of 11.0%
  • ✓Trading at only 1.3x book value

✗Weaknesses

  • ✗High debt to equity ratio of 2.9x

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

Get notified when CE posts new earnings or crosses analyst targets

Free. No account needed. Unsubscribe any time.

Free. Unsubscribe any time.

CE Price & Volume

Celanese Corporation (CE) stock price & volume — 10-year historical chart

Loading chart...

CE Growth Metrics

Celanese Corporation (CE) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years5.34%
5 Years11.03%
3 Years-0.45%
TTM-5.63%

Profit CAGR

10 Years-
5 Years-
3 Years-
TTM38.46%

EPS CAGR

10 Years-
5 Years-
3 Years-
TTM34.23%

Return on Capital

10 Years9.86%
5 Years7.64%
3 Years2.78%
Last Year4.14%

CE Recent Earnings

Celanese Corporation (CE) EPS & revenue vs analyst estimates — last 4 quarters

Full history →
●Beat EPS 6/12 qtrs (50%)●Beat Revenue 2/12 qtrs (17%)
Q2 2026Latest
May 5, 2026
Metric
Actual
Est
EPS
$0.85-4.6%
$0.89
Rev
$2.3B-0.3%
$2.3B
Q1 2026
Feb 17, 2026
Metric
Actual
Est
EPS
$0.67-24.7%
$0.89
Rev
$2.2B-2.2%
$2.3B
Q4 2025
Nov 6, 2025
Metric
Actual
Est
EPS
$1.34+5.5%
$1.27
Rev
$2.4B+7.7%
$2.2B
Q3 2025
Aug 11, 2025
Metric
Actual
Est
EPS
$1.44+4.3%
$1.38
Rev
$2.5B-0.7%
$2.5B
QuarterDateEPS (Act vs Est)Revenue (Act vs Est)
Q2 2026LatestMay 5, 2026
$0.85vs $0.89-4.6%
$2.3Bvs $2.3B-0.3%
Q1 2026Feb 17, 2026
$0.67vs $0.89-24.7%
$2.2Bvs $2.3B-2.2%
Q4 2025Nov 6, 2025
$1.34vs $1.27+5.5%
$2.4Bvs $2.2B+7.7%
Q3 2025Aug 11, 2025
$1.44vs $1.38+4.3%
$2.5Bvs $2.5B-0.7%
Based on last 12 quarters of dataView full earnings history →

CE Peer Comparison

Celanese Corporation (CE) competitors in Specialty polymers and additives — business model, growth, and fundamentals comparison

Select Columns
Stock Universe
Valuation
Growth
Profitability
Financial Health
Dividends & Buybacks
Price Performance
Technical
Fundamentals ($)
Sector-Specific
Institutional Holdings
CompanyMarket CapStock PriceP/E Ratio (TTM)Revenue Growth 1YNet MarginReturn on Equity (ROE)FCF YieldDebt / Equity
EMN logoEMNEastman Chemical CompanyDirect Competitor8.29B72.4917.68-6.71%4.62%6.69%0.84
HUN logoHUNHuntsman CorporationDirect Competitor2.1B12.07-7.59-5.85%-5.69%-8.14%0.92
AVNT logoAVNTAvient CorporationDirect Competitor3.45B37.6642.310.61%4.81%6.6%0.81
ASH logoASHAshland Inc.Direct Competitor3.11B67.92-3.70-13.68%-39.03%-37.54%0.83
TROX logoTROXTronox Holdings plcDirect Competitor1.18B7.40-2.49-5.73%-12.3%-30.42%2.48
DOW logoDOWDow Inc.Product Competitor22.83B31.73-8.60-6.97%-7.02%-15.35%1.12
LYB logoLYBLyondellBasell Industries N.V.Product Competitor19.35B60.07-25.56-25.18%-3.44%-7.2%1.56
WLK logoWLKWestlake CorporationProduct Competitor10.28B80.28-6.84-8.01%-14.91%-16.76%0.69

Compare CE vs Peers

Celanese Corporation (CE) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs EMN

Most directly comparable listed peer for CE.

Scale Benchmark

vs ECL

Larger-name benchmark to compare CE against a more recognizable public peer.

Peer Set

Compare Top 5

vs EMN, HUN, AVNT, ASH

CE Income Statement

Celanese Corporation (CE) annual income statement — 10-year revenue, gross profit & net income history

10Y historyFree accessUpdated daily
MetricDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Sales/Revenue
6.14B7.16B6.3B5.66B8.54B9.67B10.94B10.28B9.54B9.49B
Revenue Growth %
13.94%16.53%-11.99%-10.2%50.96%13.31%13.1%-6.03%-7.16%-5.63%
Cost of Goods Sold
4.63B5.18B4.69B4.36B5.86B7.29B8.34B7.92B7.75B7.58B
COGS % of Revenue
75.33%72.44%74.5%77.14%68.58%75.4%76.21%77.08%81.23%-
Gross Profit
1.51B▲ 0%
1.97B▲ 30.2%
1.61B▼ 18.6%
1.29B▼ 19.5%
2.68B▲ 107.4%
2.38B▼ 11.3%
2.6B▲ 9.4%
2.36B▼ 9.5%
1.79B▼ 24.0%
1.91B▲ 0%
Gross Margin %
24.67%27.56%25.5%22.86%31.42%24.6%23.79%22.92%18.77%20.09%
Gross Profit Growth %
7.83%30.16%-18.56%-19.49%107.42%-11.26%9.37%-9.49%-23.98%-
Operating Expenses
548M642M772M629M736M1B916M3.05B1.02B2.61B
OpEx % of Revenue
8.93%8.97%12.26%11.12%8.62%10.36%8.37%29.7%10.73%-
Selling, General & Admin
456M546M483M482M633M824M1.07B1.03B899M893M
SG&A % of Revenue
7.43%7.63%7.67%8.52%7.41%8.52%9.83%10.02%9.42%-
Research & Development
72M72M67M74M86M112M146M130M125M122M
R&D % of Revenue
1.17%1.01%1.06%1.31%1.01%1.16%1.33%1.26%1.31%-
Other Operating Expenses
-57M-45M222M73M17M66M-305M1.89B02M
Operating Income
901M▲ 0%
1.33B▲ 48.1%
834M▼ 37.5%
664M▼ 20.4%
1.95B▲ 193.1%
1.38B▼ 29.2%
1.69B▲ 22.4%
-697M▼ 141.3%
767M▲ 210.0%
-700M▲ 0%
Operating Margin %
14.67%18.64%13.24%11.74%22.79%14.25%15.42%-6.78%8.04%-7.37%
Operating Income Growth %
0.9%48.06%-37.48%-20.38%193.07%-29.19%22.42%-141.32%210.04%-
EBITDA
1.21B1.68B1.19B1.02B2.32B1.86B2.4B126M1.51B58M
EBITDA Margin %
19.64%23.44%18.9%18.04%27.22%19.19%21.92%1.23%15.82%0.61%
EBITDA Growth %
1.94%39.05%-29.04%-14.29%127.84%-20.14%29.2%-94.75%1098.41%20.83%
D&A (Non-Cash Add-back)
305M343M356M356M378M478M711M823M743M758M
EBIT
1.2B1.64B1.1B2.36B2.34B1.83B1.9B-320M-451M-430M
Net Interest Income
-120M-120M-113M-103M-92M-336M-681M-643M-745M-722M
Interest Income
2M6M6M6M8M69M39M33M24M29M
Interest Expense
122M125M119M109M100M405M720M676M769M751M
Other Income/Expense
218M176M154M1.59B302M43M-504M-299M-1.99B-430M
Pretax Income
1.07B▲ 0%
1.51B▲ 40.5%
988M▼ 34.6%
2.25B▲ 127.8%
2.25B▼ 0.1%
1.42B▼ 36.8%
1.18B▼ 16.7%
-996M▼ 184.2%
-1.22B▼ 22.5%
-1.13B▲ 0%
Pretax Margin %
17.51%21.1%15.69%39.81%26.33%14.69%10.81%-9.69%-12.78%-11.9%
Income Tax
213M292M124M247M330M-489M-790M510M-90M-132M
Effective Tax Rate %
19.81%19.34%12.55%10.97%14.68%-34.41%-66.78%-51.2%7.38%11.68%
Net Income
843M▲ 0%
1.21B▲ 43.2%
852M▼ 29.4%
1.99B▲ 133.0%
1.89B▼ 4.8%
1.89B▲ 0.2%
1.96B▲ 3.5%
-1.52B▼ 177.7%
-1.17B▲ 23.5%
-1.02B▲ 0%
Net Margin %
13.73%16.87%13.53%35.1%22.14%19.58%17.92%-14.81%-12.21%-10.79%
Net Income Growth %
-6.33%43.18%-29.41%132.98%-4.79%0.21%3.48%-177.65%23.46%38.46%
Net Income (Continuing)
862M1.22B864M2B1.92B1.91B1.97B-1.51B-1.13B-998M
Discontinued Operations
00-6M-12M-22M-8M-9M-8M-21M-2M
Minority Interest
412M395M391M369M348M468M461M434M423M422M
EPS (Diluted)
6.09▲ 0%
8.91▲ 46.3%
6.84▼ 23.2%
16.75▲ 144.9%
16.86▲ 0.7%
17.34▲ 2.8%
17.92▲ 3.3%
-13.93▼ 177.7%
-10.64▲ 23.6%
-9.31▲ 0%
EPS Growth %
-1.46%46.31%-23.23%144.88%0.66%2.85%3.34%-177.73%23.62%34.23%
EPS (Basic)
6.118.996.8816.8516.9917.4818.01-13.93-10.64-
Diluted Shares Outstanding
138.3M135.4M124.65M118.48M112.08M109.24M109.38M109.27M109.5M110M
Basic Shares Outstanding
137.9M134.3M123.93M117.8M111.22M108.38M108.85M109.27M109.5M109.7M
Dividend Payout Ratio
28.59%23.2%35.21%14.76%16.08%15.68%15.56%---

CE Balance Sheet

Celanese Corporation (CE) balance sheet — assets, liabilities & shareholders' equity

MetricDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Total Current Assets
2.79B2.87B2.77B3.76B3.81B6.61B6.22B5.14B5.69B5.97B
Cash & Short-Term Investments
608M470M503M1.49B546M1.51B1.8B962M1.26B1.76B
Cash Only
576M439M463M955M536M1.51B1.8B962M1.26B1.76B
Short-Term Investments
32M31M40M533M10M00000
Accounts Receivable
1.23B1.32B1.18B1.24B1.67B2.05B1.78B1.61B1.47B1.68B
Days Sales Outstanding
73.1267.2468.4680.1671.2777.5159.5257.3156.165
Inventory
900M1.05B1.04B978M1.52B2.81B2.36B2.28B2.22B2.28B
Days Inventory Outstanding
71.0373.6680.7781.8495.01140.53103.19105.21104.51108.33
Other Current Assets
54M40M43M55M70M241M272M285M743M247M
Total Non-Current Assets
6.75B6.44B6.71B7.15B8.17B19.66B20.38B17.71B16B15.77B
Property, Plant & Equipment
3.76B3.72B3.92B4.17B4.43B6B6.01B5.66B5.43B4.94B
Fixed Asset Turnover
1.63x1.92x1.61x1.36x1.93x1.61x1.82x1.82x1.76x1.76x
Goodwill
1B1.06B1.07B1.17B1.41B7.14B6.98B5.39B4.17B4.16B
Intangible Assets
301M310M312M319M735M4.11B3.98B3.64B3.18B3.12B
Long-Term Investments
976M979M975M820M823M1.06B1.22B1.22B1.25B5B
Other Non-Current Assets
338M290M338M411M521M547M524M555M601M984M
Total Assets
9.54B▲ 0%
9.31B▼ 2.4%
9.48B▲ 1.8%
10.91B▲ 15.1%
11.97B▲ 9.8%
26.27B▲ 119.4%
26.6B▲ 1.2%
22.86B▼ 14.1%
21.7B▼ 5.1%
21.73B▲ 0%
Asset Turnover
0.64x0.77x0.66x0.52x0.71x0.37x0.41x0.45x0.44x0.43x
Asset Growth %
14.13%-2.36%1.75%15.12%9.77%119.39%1.24%-14.06%-5.08%-33.9%
Total Current Liabilities
1.56B1.78B1.75B1.97B2.5B4.07B4.07B3.85B3.68B4.32B
Accounts Payable
807M819M780M797M1.16B1.52B1.51B1.23B1.28B1.44B
Days Payables Outstanding
63.6957.6860.6966.6972.3175.9766.1156.5660.2163.17
Short-Term Debt
326M561M496M496M791M1.31B1.38B1.5B1.2B1.74B
Deferred Revenue (Current)
72M78M00248M00000
Other Current Liabilities
166M107M279M494M108M594M516M390M596M1.13B
Current Ratio
1.79x1.62x1.58x1.91x1.52x1.63x1.53x1.34x1.55x1.38x
Quick Ratio
1.21x1.03x0.98x1.41x0.91x0.93x0.95x0.74x0.94x0.85x
Cash Conversion Cycle
80.4683.2288.5395.3193.96142.0796.6105.95100.4110.16
Total Non-Current Liabilities
4.68B4.16B4.82B5.04B4.93B16.1B14.97B13.39B13.54B12.93B
Long-Term Debt
3.31B2.97B3.41B3.06B3.03B13.37B12.3B11.08B11.39B10.81B
Capital Lease Obligations
0143M181M379M348M364M325M294M265M838M
Deferred Tax Liabilities
367M413M257M509M555M1.24B999M933M512M2.4B
Other Non-Current Liabilities
1.1B736M928M1.05B1B1.12B1.35B1.09B1.37B1.61B
Total Liabilities
6.24B5.93B6.58B7.01B7.44B20.17B19.05B17.25B17.22B17.25B
Total Debt
3.64B3.53B4.12B3.97B4.2B15.13B14.1B12.95B12.93B12.55B
Net Debt
3.06B3.09B3.65B3.01B3.67B13.62B12.29B11.99B11.67B10.8B
Debt / Equity
1.10x1.04x1.42x1.02x0.93x2.48x1.87x2.31x2.89x2.80x
Debt / EBITDA
3.02x2.11x3.46x3.89x1.81x8.15x5.88x102.79x8.57x216.45x
Net Debt / EBITDA
2.54x1.84x3.07x2.95x1.58x7.34x5.13x95.16x7.73x186.14x
Interest Coverage
9.81x13.08x9.27x21.65x23.39x4.51x2.64x-0.47x-0.59x-0.57x
Total Equity
3.3B▲ 0%
3.38B▲ 2.4%
2.9B▼ 14.2%
3.9B▲ 34.4%
4.54B▲ 16.5%
6.11B▲ 34.6%
7.55B▲ 23.7%
5.61B▼ 25.7%
4.47B▼ 20.3%
4.49B▲ 0%
Equity Growth %
9.2%2.43%-14.24%34.4%16.48%34.56%23.7%-25.73%-20.27%-108.69%
Book Value per Share
23.8524.9623.2532.8740.4855.8969.0451.3340.8440.77
Total Shareholders' Equity
2.89B2.98B2.51B3.53B4.19B5.64B7.09B5.17B4.05B4.06B
Common Stock
0000000000
Retained Earnings
4.92B5.85B6.4B8.09B9.68B11.27B12.93B11.1B9.88B9.92B
Treasury Stock
-2.03B-2.85B-3.85B-4.49B-5.49B-5.49B-5.49B-5.49B-5.48B-5.48B
Accumulated OCI
-177M-247M-300M-328M-329M-518M-744M-848M-776M-811M
Minority Interest
412M395M391M369M348M468M461M434M423M422M

CE Cash Flow Statement

Celanese Corporation (CE) cash flow — operating, investing & free cash flow history

MetricDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Cash from Operations
803M1.56B1.45B1.34B1.76B1.82B1.9B966M1.15B1.19B
Operating CF Margin %
13.08%21.77%23.09%23.75%20.58%18.8%17.36%9.4%12.01%-
Operating CF Growth %
-10.08%94.02%-6.68%-7.63%30.83%3.53%4.4%-49.13%18.63%562.65%
Net Income
849M1.21B858M2B1.89B1.9B1.96B-1.51B-1.14B-1.02B
Depreciation & Amortization
310M349M356M356M378M478M711M823M777M578M
Stock-Based Compensation
47M71M48M28M95M60M40M32M014M
Deferred Taxes
-152M137M-31M77M13M-835M-967M216M-278M-298M
Other Non-Cash Items
-424M36M72M-1.4B-131M-66M-365M1.61B1.56B1.54B
Working Capital Changes
173M-248M151M280M-488M280M516M-204M235M432M
Change in Receivables
-110M-48M165M141M-396M218M105M92M213M312M
Change in Inventory
-97M-158M6M124M-367M-253M398M11M154M140M
Change in Payables
126M15M-59M-6M353M-84M20M-234M26M-67M
Cash from Investing
-549M-507M-493M592M-1.12B-11.14B-134M-470M-349M174M
Capital Expenditures
-267M-337M-370M-364M-467M-543M-568M-435M-343M-241M
CapEx % of Revenue
4.35%4.71%5.88%6.44%5.47%5.61%5.19%4.23%3.59%2.54%
Acquisitions
-268M-131M-90M1.5B-1.11B-10.54B532M021M15M
Investments
----------
Other Investing
-14M-39M-387M-1.61B-520M-57M-98M-52M-27M400M
Cash from Financing
-351M-1.17B-935M-1.47B-1.04B10.29B-1.46B-1.31B-513M-561M
Debt Issued (Net)
443M-40M412M-472M404M10.78B-1.09B-948M-323M-449M
Equity Issued (Net)
-500M-805M-996M-650M-1B-17M01M00
Dividends Paid
-241M-280M-300M-293M-304M-297M-305M-307M-13M-10M
Share Repurchases
-500M-805M-996M-650M-1B-17M0000
Other Financing
-53M-40M-51M-56M-142M-175M-63M-59M-177M-102M
Net Change in Cash
-62M▲ 0%
-137M▼ 121.0%
24M▲ 117.5%
492M▲ 1950.0%
-419M▼ 185.2%
972M▲ 332.0%
297M▼ 69.4%
-843M▼ 383.8%
301M▲ 135.7%
810M▲ 0%
Free Cash Flow
536M▲ 0%
1.22B▲ 127.8%
1.08B▼ 11.2%
979M▼ 9.7%
1.29B▲ 31.8%
1.28B▼ 1.1%
1.33B▲ 4.3%
531M▼ 60.1%
803M▲ 51.2%
944M▲ 0%
FCF Margin %
8.73%17.07%17.21%17.31%15.11%13.19%12.17%5.17%8.41%9.95%
FCF Growth %
-17.16%127.8%-11.22%-9.69%31.77%-1.09%4.31%-60.11%51.22%88.05%
FCF per Share
3.889.028.708.2611.5111.6812.174.867.338.58
FCF Conversion (FCF/Net Income)
0.95x1.29x1.71x0.68x0.93x0.96x0.97x-0.63x-0.98x-0.92x
Interest Paid
130M133M118M120M105M122M780M701M00
Taxes Paid
123M100M157M167M215M122M780M701M00

CE Key Ratios

Celanese Corporation (CE) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios

Metric201720182019202020212022202320242025TTM
Return on Equity (ROE)
26.68%36.15%27.15%58.44%44.83%35.59%28.7%-23.13%-23.11%-21.51%
Return on Invested Capital (ROIC)
11.5%15.59%9.61%7.4%19.32%7.4%6.4%-2.79%3.41%-3.21%
Gross Margin
24.67%27.56%25.5%22.86%31.42%24.6%23.79%22.92%18.77%20.09%
Net Margin
13.73%16.87%13.53%35.1%22.14%19.58%17.92%-14.81%-12.21%-10.79%
Debt / Equity
1.10x1.04x1.42x1.02x0.93x2.48x1.87x2.31x2.89x2.80x
Interest Coverage
9.81x13.08x9.27x21.65x23.39x4.51x2.64x-0.47x-0.59x-0.57x
FCF Conversion
0.95x1.29x1.71x0.68x0.93x0.96x0.97x-0.63x-0.98x-0.92x
Revenue Growth
13.94%16.53%-11.99%-10.2%50.96%13.31%13.1%-6.03%-7.16%-5.63%
Related:CE Dividend History·CE Revenue History·CE Price History·CE P/E History·CE Financial Ratios·CE Institutional Holders

CE SEC Filings & Documents

Celanese Corporation (CE) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

6
Material company update

May 5, 2026·SEC

Material company update

May 5, 2026·SEC

Material company update

Apr 20, 2026·SEC

10-K Annual Reports

2
FY 2026

Feb 24, 2026·SEC

FY 2025

Feb 21, 2025·SEC

10-Q Quarterly Reports

6
FY 2026

May 6, 2026·SEC

FY 2025

Nov 7, 2025·SEC

FY 2025

Aug 11, 2025·SEC

CE Frequently Asked Questions

Celanese Corporation (CE) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials

Celanese Corporation (CE) reported $9.49B in revenue for fiscal year 2025. This represents a 147% increase from $3.84B in 2001.

Celanese Corporation (CE) saw revenue decline by 7.2% over the past year.

Celanese Corporation (CE) reported a net loss of $1.02B for fiscal year 2025.

Dividend & Returns

Yes, Celanese Corporation (CE) pays a dividend with a yield of 0.23%. This makes it attractive for income-focused investors.

Celanese Corporation (CE) has a return on equity (ROE) of -23.1%. Negative ROE indicates the company is unprofitable.

Celanese Corporation (CE) generated $944.0M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

What if you invested $1,000 in CE back in 2001?

Total return calculator · dividends reinvested · 25+ years of data

See returns →

How much would $100/month in CE be worth today?

Dollar cost averaging calculator · DCA vs lump sum

Calculate →